265 related articles for article (PubMed ID: 16762401)
21. Hazard identification of imidacloprid to aquatic environment.
Tisler T; Jemec A; Mozetic B; Trebse P
Chemosphere; 2009 Aug; 76(7):907-14. PubMed ID: 19505710
[TBL] [Abstract][Full Text] [Related]
22. An exposure assessment for selected pharmaceuticals within a watershed in Southern Ontario.
Lissemore L; Hao C; Yang P; Sibley PK; Mabury S; Solomon KR
Chemosphere; 2006 Jul; 64(5):717-29. PubMed ID: 16403551
[TBL] [Abstract][Full Text] [Related]
23. Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization.
Schmitt H; Boucard T; Garric J; Jensen J; Parrott J; Péry A; Römbke J; Straub JO; Hutchinson TH; Sánchez-Argüello P; Wennmalm A; Duis K
Integr Environ Assess Manag; 2010 Jul; 6 Suppl():588-602. PubMed ID: 19958048
[TBL] [Abstract][Full Text] [Related]
24. Biomarkers in aquatic plants: selection and utility.
Brain RA; Cedergreen N
Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
[TBL] [Abstract][Full Text] [Related]
25. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals.
Berninger JP; Brooks BW
Toxicol Lett; 2010 Mar; 193(1):69-78. PubMed ID: 20025941
[TBL] [Abstract][Full Text] [Related]
26. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
[TBL] [Abstract][Full Text] [Related]
27. Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action.
Christen V; Hickmann S; Rechenberg B; Fent K
Aquat Toxicol; 2010 Feb; 96(3):167-81. PubMed ID: 20053463
[TBL] [Abstract][Full Text] [Related]
28. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
Christensen AM; Markussen B; Baun A; Halling-Sørensen B
Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
[TBL] [Abstract][Full Text] [Related]
29. Predicted critical environmental concentrations for 500 pharmaceuticals.
Fick J; Lindberg RH; Tysklind M; Larsson DG
Regul Toxicol Pharmacol; 2010 Dec; 58(3):516-23. PubMed ID: 20816909
[TBL] [Abstract][Full Text] [Related]
30. First report on interspecies quantitative correlation of ecotoxicity of pharmaceuticals.
Kar S; Roy K
Chemosphere; 2010 Oct; 81(6):738-47. PubMed ID: 20692010
[TBL] [Abstract][Full Text] [Related]
31. Ecological and toxicological effects of inorganic nitrogen pollution in aquatic ecosystems: A global assessment.
Camargo JA; Alonso A
Environ Int; 2006 Aug; 32(6):831-49. PubMed ID: 16781774
[TBL] [Abstract][Full Text] [Related]
32. Mixture toxicity of the antiviral drug Tamiflu((R)) (oseltamivir ethylester) and its active metabolite oseltamivir acid.
Escher BI; Bramaz N; Lienert J; Neuwoehner J; Straub JO
Aquat Toxicol; 2010 Feb; 96(3):194-202. PubMed ID: 19939473
[TBL] [Abstract][Full Text] [Related]
33. Application of quantitative structure--activity relationships for assessing the aquatic toxicity of phthalate esters.
Parkerton TF; Konkel WJ
Ecotoxicol Environ Saf; 2000 Jan; 45(1):61-78. PubMed ID: 10677269
[TBL] [Abstract][Full Text] [Related]
34. Comparison of a score-based approach with risk-based ranking of in-use agricultural pesticides in Canada to aquatic receptors.
Whiteside M; Mineau P; Morrison C; Knopper LD
Integr Environ Assess Manag; 2008 Apr; 4(2):215-36. PubMed ID: 18237227
[TBL] [Abstract][Full Text] [Related]
35. Environmental hazard assessment of pharmaceuticals.
Henschel KP; Wenzel A; Diedrich M; Fliedner A
Regul Toxicol Pharmacol; 1997 Jun; 25(3):220-5. PubMed ID: 9237324
[TBL] [Abstract][Full Text] [Related]
36. How well can we predict the toxicity of pesticide mixtures to aquatic life?
Belden JB; Gilliom RJ; Lydy MJ
Integr Environ Assess Manag; 2007 Jul; 3(3):364-72. PubMed ID: 17695109
[TBL] [Abstract][Full Text] [Related]
37. Managing emissions of active pharmaceutical ingredients from manufacturing facilities: an environmental quality standard approach.
Murray-Smith RJ; Coombe VT; Grönlund MH; Waern F; Baird JA
Integr Environ Assess Manag; 2012 Apr; 8(2):320-30. PubMed ID: 22057894
[TBL] [Abstract][Full Text] [Related]
38. Initial ecological risk assessment of eight selected human pharmaceuticals in Japan.
Yamamoto H; Nakamura Y; Nakamura Y; Kitani C; Imari T; Sekizawa J; Takao Y; Yamashita N; Hirai N; Oda S; Tatarazako N
Environ Sci; 2007; 14(4):177-93. PubMed ID: 17762841
[TBL] [Abstract][Full Text] [Related]
39. Direct toxicity assessment of volatile chlorinated hydrocarbon-contaminated groundwater and derivation of a site-specific guideline.
Hunt J; Birch G; Warne MS; Krassoi R
Integr Environ Assess Manag; 2009 Apr; 5(2):338-48. PubMed ID: 19125544
[TBL] [Abstract][Full Text] [Related]
40. Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris.
Pascoe D; Karntanut W; Müller CT
Chemosphere; 2003 May; 51(6):521-8. PubMed ID: 12615105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
